LOS ANGELES, May 1, 2014 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient’s response to cancer therapy, will announce its first quarter 2014 financial results and give an operational update in a press release to be issued before the market opens on Thursday, May 8, 2014. The company will host a conference call that same day at 8:30 a.m. EDT to discuss its financial results.
Help employers find you! Check out all the jobs and post your resume.
